Show simple item record

dc.contributor.authorKeshavarz, M
dc.contributor.authorDianat-Moghadam, H
dc.contributor.authorSofiani, VH
dc.contributor.authorKarimzadeh, M
dc.contributor.authorZargar, M
dc.contributor.authorMoghoofei, M
dc.contributor.authorBiglari, H
dc.contributor.authorGhorbani, S
dc.contributor.authorNahand, JS
dc.contributor.authorMirzaei, H
dc.date.accessioned2018-08-26T04:52:53Z
dc.date.available2018-08-26T04:52:53Z
dc.date.issued2018
dc.identifier10.2217/epi-2017-0170
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/37731
dc.description.abstractInfluenza A virus is known worldwide as a threat associated with human and livestock diseases. Hence, identification of physiological and molecular aspects of influenza A could contribute to better design of therapeutic approaches for reducing adverse effects associated with disease caused by this virus. miRNAs are epigenetic regulators playing important roles in many pathological processes that help in progression of influenza A. Besides miRNAs, exosomes have ememrged as other effective players in influenza A pathogenesis. Exosomes exert their effects via targeting their cargos (e.g., DNAs, mRNA, miRNAs and proteins) to recipient cells. Here, we summarized various roles of miRNAs and exosomes in influenza A pathogenesis. Moreover, we highlighted therapeutic applications of miRNAs and exosomes in influenza.
dc.language.isoEnglish
dc.relation.ispartofEpigenomics
dc.titlemiRNA-based strategy for modulation of influenza A virus infection.
dc.typearticle
dc.citation.volume10
dc.citation.issue6
dc.citation.spage829
dc.citation.epage844
dc.citation.indexPubmed
dc.identifier.DOIhttps://doi.org/10.2217/epi-2017-0170


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record